M. Lonberg

Dasatinib and docetaxel combination treatment for patients with castration-resistant progressive prostate cancer: A phase I/II study (CA180086).

A. Armstrong, C. Logothetis, E. Posadas, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Light chain variants of an IgG3 anti-GD3 monoclonal antibody and the relationship among avidity, effector functions, tumor targeting, and antitumor activity.

A. Houghton, P. Chapman, M. Lonberg, 1990, Cancer research.

Combined Fludarabine and Rituximab for Low Grade Lymphoma and Chronic Lymphocytic Leukemia

D. Heitjan, C. Hesdorffer, D. Savage, 2003, Leukemia & lymphoma.

Treatment of human metastatic melanoma with mouse monoclonal antibodies against GD3 ganglioside.

D. Bajorin, A. Houghton, P. Chapman, 1989, Progress in clinical and biological research.

Kaposi's sarcoma and AIDS.

F. Muggia, M. Lonberg, 1986, The Medical clinics of North America.

Treatment of epidemic Kaposi's sarcoma with a combination of interferon-alpha 2b and etoposide.

C. Slywotzky, F. Muggia, M. Green, 1988, Journal of biological response modifiers.

Dasatinib combined with docetaxel for castration‐resistant prostate cancer

A. Armstrong, C. Logothetis, E. Posadas, 2012, Cancer.